Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
BMC Womens Health ; 23(1): 259, 2023 05 12.
Article in English | MEDLINE | ID: mdl-37173714

ABSTRACT

BACKGROUND: Pre-eclampsia may be associated with the development of endometrial cancer; however, previous findings have been conflicting. OBJECTIVES: To investigate if pre-eclampsia is associated with an increased risk of endometrial cancer. METHOD: Two independent reviewers screened titles and abstracts of studies identified in MEDLINE, Embase, and Web of Science databases from inception until March 2022. Studies were included if they investigated pre-eclampsia and subsequent risk of endometrial cancer (or precursor lesions). Random-effects meta-analysis was used to calculate pooled hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between pre-eclampsia during pregnancy and endometrial cancer risk. MAIN RESULTS: There were seven articles identified which investigated endometrial cancer, of which one also investigated endometrial cancer precursors. Overall, the studies include 11,724 endometrial cancer cases. No association was observed between pre-eclampsia and risk of endometrial cancer with moderate heterogeneity observed (pooled HR 1.07, 95% CI 0.79-1.46, I2 = 34.1%). In sensitivity analysis investigating risk of endometrial neoplasia (atypical hyperplasia, carcinoma in situ, or cancer), there was some evidence that pre-eclampsia was associated with an increased risk (HR 1.34, 95% CI 1.15-1.57, I2 = 29.6%). CONCLUSIONS: Pre-eclampsia was not associated with an increased risk of endometrial cancer. Additional large studies with information on pre-eclampsia sub-type aiming to investigate endometrial cancer precursor conditions are merited.


Subject(s)
Endometrial Neoplasms , Pre-Eclampsia , Pregnancy , Female , Humans , Pre-Eclampsia/epidemiology , Pre-Eclampsia/etiology , Endometrial Neoplasms/epidemiology
2.
Curr Microbiol ; 36(3): 136-47, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9516541

ABSTRACT

Biodegradation of ethylene glycol was tested in a laboratory-scale, steady-state infiltration system of two arid region soil types by monitoring indigenous microbial growth after the infiltration of three concentrations of ethylene glycol. Microorganisms in the soils were able to adapt to the ethylene glycol in several cases, resulting in higher numbers of microorganisms and lower pHs in the effluents. These microorganisms were identified and were able to use ethylene glycol as a sole carbon source. The adaptation was seen best with high-moisture-content soils when the ethylene glycol concentrations were 1% or 10%. However, acclimation to 0.1% and 10% ethylene glycol did not occur in low-moisture-content clay soil, but did occur in low-moisture-content silt soil, indicating that soil type and moisture content are important factors. In all cases, microbial diversity decreased over time.


Subject(s)
Bacteria/drug effects , Bacteria/growth & development , Ethylene Glycol/pharmacology , Soil Microbiology , Biodegradation, Environmental , Calcium Carbonate/metabolism , Dose-Response Relationship, Drug , Environmental Pollutants/pharmacology , Ethylene Glycol/administration & dosage , Humidity/standards , Hydrogen-Ion Concentration , Models, Biological , Soil/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...